Orchid Pharma Ltd vs Sunrest Lifescience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 11, 2026

Key Highlights

The Latest Trading Price of Orchid Pharma Ltd is ₹ 849.55 as of 11 Jun 12:14 . The P/E Ratio of Orchid Pharma Ltd changed from 33.9 on March 2023 to 39.5 on March 2025 . This represents a CAGR of 5.23% over 3 yearsThe P/E Ratio of Sunrest Lifescience Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Orchid Pharma Ltd changed from ₹ 10061 crore on March 2021 to ₹ 3940 crore on March 2025 . This represents a CAGR of -17.10% over 5 yearsThe Market Cap of Sunrest Lifescience Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Orchid Pharma Ltd for the Mar '26 is ₹ 245.49 crore as compare to the Dec '25 revenue of ₹ 212.88 crore. This represent the growth of 15.32% The revenue of Sunrest Lifescience Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Orchid Pharma Ltd for the Mar '26 is ₹ 34.75 crore as compare to the Dec '25 ebitda of ₹ 0.06 crore. This represent the growth of 57816% The ebitda of Sunrest Lifescience Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Orchid Pharma Ltd changed from ₹ 28.27 crore to ₹ 22.79 crore over 8 quarters. This represents a CAGR of -10.21% The net profit of Sunrest Lifescience Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Orchid Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sunrest Lifescience Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Orchid Pharma Ltd

Orchid Pharma Limited, is a vertically integrated pharmaceutical company with established research, manufacturing and marketing capabilities across multi-therapeutic domains.
Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India.
The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai. The Company has a portfolio of antibiotics, and veterinary products.
Antibiotics are life-saving drugs used to ght infections.
Different classes of antibiotics include Beta-lactam, Macrolide, Fluoroquinolone, Imidazoleetc.

About Sunrest Lifescience Ltd

Sunrest Lifescience Limited was originally incorporated as 'Sunrest Lifescience Private Limited' as a Private Company vide Certificate of Incorporation dated October 30, 2017, with the Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to 'Sunrest Lifescience Limited' on March 21, 2023. The Company is engaged in marketing of OTC generic pharmaceutical products into domestic market.
The Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan.
It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste.
Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.

FAQs for the comparison of Orchid Pharma Ltd and Sunrest Lifescience Ltd

Which company has a larger market capitalization, Orchid Pharma Ltd or Sunrest Lifescience Ltd?

Market cap of Orchid Pharma Ltd is 4,312 Cr while Market cap of Sunrest Lifescience Ltd is 27 Cr

What are the key factors driving the stock performance of Orchid Pharma Ltd and Sunrest Lifescience Ltd?

The stock performance of Orchid Pharma Ltd and Sunrest Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Orchid Pharma Ltd and Sunrest Lifescience Ltd?

As of June 11, 2026, the Orchid Pharma Ltd stock price is INR ₹850.35. On the other hand, Sunrest Lifescience Ltd stock price is INR ₹32.15.

How do dividend payouts of Orchid Pharma Ltd and Sunrest Lifescience Ltd compare?

To compare the dividend payouts of Orchid Pharma Ltd and Sunrest Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.